12.11.2024, 18:22 116221

Kazakhstan intends to transform its drug procurement management system

Kazakhstan intends to transform its drug procurement management system
Chairman of the Board of SK-Pharmacy LLP Yerken Zhakatayev reported at the Government session that in recent years the state has significantly increased the list of medicines guaranteed to be provided to patients, primeminister.kz reports.

In general, the volume of drugs and medical products purchased by the Single Distributor has increased 15 times in monetary terms compared to 2010. Today SK-Pharmacia provides medicines and medical products to more than 1.2 thousand inpatient centres and 700 polyclinics across the country. In the current year in the list of ‘SK-Pharmacy’ already 1588 names of pharmaceutical products for 480 billion tenge. Long-term contracts have been concluded with 35 domestic manufacturers for the supply of almost 4 thousand names of medicines and medical devices.

‘These indicators were achieved by centralisation of procurement, which led to the effect of price equalisation throughout the country, regardless of the distance of the region," Yerken Zhakataev noted

It was noted that medicines are supplied to medical organisations of the republic by six logistics providers. At the beginning of its activity in 2009, SK-Pharmacia had only one warehouse, which limited the possibility of timely deliveries throughout the country. Today, under the concluded contracts, there are 14 modern warehouses with a total area of about 300 thousand m3 strategically located throughout Kazakhstan and equipped with the latest systems for controlling temperature and storage conditions. This ensures the safety and security of all medicines and medical devices.

In the future it is planned to transform procurement management systems with a focus on key functional areas of the company. In particular, according to the announcement, full automation of procurement procedures from planning to purchasing will be implemented, and a unified information base will be created with further integration into the healthcare ecosystem.

We actively support the development of domestic pharmaceutical production, concluding long-term contracts with Kazakhstani manufacturers. We are confident that our systematic work to provide medical institutions with vital drugs and products contributes to the sustainable development of healthcare and improves the quality of medical care for all citizens of the country," Yerken Zhakatayev emphasised.

 

This information may not be reproduced without reference to Kazakhstan Today. Copyright of materials of News Agency Kazakhstan Today.


Found an error in the text?

Select the error and press Ctrl + Enter at the same time.

relevant news

Most viewed